Cyclosporine A transfer between high- and low-density lipoproteins: Independent from lipid transfer protein I-facilitated transfer of lipoprotein-coated phospholipids because of high affinity of cyclosporine A for the protein component of lipoproteins

Journal of Pharmaceutical Sciences

Volumn 90, Issue 9, 2001, Pages 1308-1317

  Kwong, Mona ^a   Sivak, Olena ^a   Kwong, Evan H ^a   Wasan, Kishor M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cyclosporine; HDL2; HDL3; Lipid transfer protein I; Lipoprotein protein content; Lipoproteins; Phospholipids

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; CYCLOSPORIN A; HIGH DENSITY LIPOPROTEIN; LIPID TRANSFER PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; TRIACYLGLYCEROL;

ACTIVE TRANSPORT; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG DISTRIBUTION; DRUG TRANSPORT; DYSLIPIDEMIA; HYDROPHOBICITY; LIPID COMPOSITION; PROTEIN CONTENT; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; SCATCHARD PLOT;

EID: 0034833757     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.1083     Document Type: Article

References (30)

1. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma
2. Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein
3. Inter-relationships of lipid transferred by the lipid transfer protein isolated from human lipoprotein-deficient plasma
4. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes
5. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins. Role of lipid transfer protein
6. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: In vitro studies in normolipidemic and dyslipidemic human plasmas
7. Lipid transfer protein I facilitated transfer of cyclosporine from low- to high-density lipoproteins is only partially dependent on its cholesteryl ester transfer activity
8. Cyclosporine transfer from low- and high-density lipoproteins is partially influenced by lipid transfer protein I triglyceride transfer activity
9. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine
10. Influence of blood components on the tissue uptake indices of cyclosporin in rats
11. Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone
12. Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A
13. Lipoprotein levels and post-heparin lipase activities in kidney transplant recipients: Ciclosporin- versus non-ciclosporin-treated patients
14. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: Role in dyslipidemia
15. Central nervous system toxicity after liver transplantation
16. High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridemia
17. Cyclosporin leukoencephalopathy induced by intravenous lipid solution
18. The human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers
19. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
20. A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine
21. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
22. Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles
23. A one-step separation of human serum high-density lipoproteins 2 and 3 by rate-zonal density gradient ultracentrifugation in a swinging bucket rotor
24. Electrophoretic separation of LDL and HDL subclasses
25. 3 is a consequence of high-density lipoprotein coat lipid content
26. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma
27. Structure-function relationships of human cholesteryl ester transfer protein: Analysis using monoclonal antibodies
28. Modifications in high density lipoprotein lipid core composition and structure alters the plasma distribution of free and liposomal annamycin
29. Structure of human serum lipoprotein inferred from compositional analysis
30. Interaction of cyclosporine A with human lipoproteins